Festina lente: hydroxychloroquine, COVID-19 and the role of the rheumatologist

Affiliations

• ¹ Division of Rheumatology and Clinical Immunology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
• ² Department of Medicine, Division of Rheumatology, University of Washington, Seattle, WA, United States.
• ³ Department of Medicine, Division of Rheumatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
• ⁴ Health Research & Policy, Division of Epidemiology and Department of Medicine, Division of Immunology & Rheumatology, Stanford School of Medicine, Stanford, California, USA.
• ⁵ Department of Medicine, Clinical Epidemiology Unit, Sweden.
• ⁶ McMaster University, Hamilton, Ontario, Canada.
• ⁷ Department of Rheumatology, Sorbonne Université, Paris, France.
• ⁸ Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA.
• ⁹ Malaghan Institute of Medical Research, Wellington, New Zealand.
• ¹⁰ LupusChat, New York, New York, USA.
• ¹¹ Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
• ¹² Department of Nephrology and Rheumatology, University Medical Center Göttingen, Göttingen, Germany.
• ¹³ Canadian Arthritis Patient Alliance, Ottawa, Ontario, Canada.
• ¹⁴ Princess Alexandra Hospital, Diamantina Institute, University of Queensland, Brisbane, Queensland, Australia.
• ¹⁵ Division of Rheumatology, Hospital for Special Surgery, New York, New York, USA.
• ¹⁶ Universidad Cientifica del Sur, Lima, Peru.
• ¹⁷ University of Texas Southwestern Medical School, Dallas, Texas, USA.
• ¹⁸ Division of Rheumatology, Department of Medicine, Washington University School of Medicine in St. Louis, Saint Louis, Missouri, USA jsparks@bwh.harvard.edu akim@wustl.edu.
• ¹⁹ Division of Rheumatology, Inflammation, and Immunity, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA jsparks@bwh.harvard.edu akim@wustl.edu.